QBI CORONAVIRUS RESEARCH GROUP

Scientists at the UC San Francisco (UCSF) Quantitative Biosciences Institute (QBI) and the QBI Coronavirus Research Group (QCRG) have been initially awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness. The award covers a three-year period and establishes one of the country’s first Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern, which are multidisciplinary academic-industry research centers to develop candidate antivirals for COVID-19 and other viruses with pandemic potential.